All‐cause mortality (within 30‐days after surgery: any reported death) · adults undergoing cardiac surgery
Alpha‐2 adrenergic agonists showed no clear difference in all‐cause mortality (within 30‐days after surgery: any reported death) compared with control (moderate certainty).
1 finding from 1 review
Cardiac mortality · adults undergoing cardiac surgery
1 finding from 1 review
Myocardial infarction (within 30‐days after surgery: sudden death or death resulting from a primarily identifiable cardiac cause) · adults undergoing cardiac surgery
Alpha‐2 adrenergic agonists showed no clear difference in myocardial infarction (within 30‐days after surgery: sudden death or… compared with control (moderate certainty).
1 finding from 1 review
All‐cause mortality (30 days)—cardiac surgery · patients with coronary heart disease and/or valvular heart disease
Beta‐blocker showed no clear difference in all‐cause mortality (30 days)—cardiac surgery compared with control—cardiac surgery (moderate certainty).
1 finding from 1 review
Cerebrovascular events—non‐cardiac surgery · patients with conditions requiring non‐cardiac surgery
Beta‐blocker showed no clear difference in cerebrovascular events—non‐cardiac surgery compared with control—non‐cardiac surgery (low certainty).
1 finding from 1 review
Ventricular arrhythmias—non‐cardiac surgery ECG · patients with conditions requiring non‐cardiac surgery
Beta‐blocker showed no clear difference in ventricular arrhythmias—non‐cardiac surgery ECG compared with control—non‐cardiac surgery (moderate certainty).
1 finding from 1 review
All supraventricular arrhythmias—non‐cardiac surgery ECG · patients with conditions requiring non‐cardiac surgery
Beta‐blocker leads to lower all supraventricular arrhythmias—non‐cardiac surgery ECG compared with control—non‐cardiac surgery (high certainty).
1 finding from 1 review
Bradycardia—non‐cardiac surgery ECG · patients with conditions requiring non‐cardiac surgery
Beta‐blocker probably leads to higher bradycardia—non‐cardiac surgery ECG compared with control—non‐cardiac surgery (moderate certainty).
1 finding from 1 review
Hypotension—non‐cardiac surgery · patients with conditions requiring non‐cardiac surgery
Beta‐blocker leads to higher hypotension—non‐cardiac surgery compared with control—non‐cardiac surgery (high certainty).
1 finding from 1 review
Acute myocardial infarction—cardiac surgery · patients with coronary heart disease and/or valvular heart disease
Beta‐blocker showed no clear difference in acute myocardial infarction—cardiac surgery compared with control—cardiac surgery (moderate certainty).
1 finding from 1 review
Cerebrovascular events—cardiac surgery · patients with coronary heart disease and/or valvular heart disease
Beta‐blocker showed no clear difference in cerebrovascular events—cardiac surgery compared with control—cardiac surgery (low certainty).
1 finding from 1 review
Ventricular arrhythmias—cardiac surgery ECG · patients with coronary heart disease and/or valvular heart disease
Beta‐blocker probably leads to lower ventricular arrhythmias—cardiac surgery ECG compared with control—cardiac surgery (moderate certainty).
1 finding from 1 review
All supraventricular arrhythmias—cardiac surgery ECG · patients with coronary heart disease and/or valvular heart disease
Beta‐blocker leads to lower all supraventricular arrhythmias—cardiac surgery ECG compared with control—cardiac surgery (high certainty).
1 finding from 1 review
Bradycardia · patients with coronary heart disease and/or valvular heart disease
Beta‐blocker showed no clear difference in bradycardia—cardiac surgery ECG compared with control—cardiac surgery (low certainty).
1 finding from 1 review
Hypotension—cardiac surgery · patients with coronary heart disease and/or valvular heart disease
Beta‐blocker showed no clear difference in hypotension—cardiac surgery compared with control—cardiac surgery (low certainty).
1 finding from 1 review
All‐cause mortality (30 days)—non‐cardiac surgery · patients with conditions requiring non‐cardiac surgery
Beta‐blocker showed no clear difference in all‐cause mortality (30 days)—non‐cardiac surgery compared with control—non‐cardiac surgery (low certainty).
1 finding from 1 review
Acute myocardial infarction—non‐cardiac surgery · patients with conditions requiring non‐cardiac surgery
Beta‐blocker leads to lower acute myocardial infarction—non‐cardiac surgery compared with control—non‐cardiac surgery (high certainty).
1 finding from 1 review
Persistent pain 3 to 18 months after thoracotomy (We defined persistent postsurgical pain as new pain that did not exist before the operation, measured using differences in scores based on validated pain scales; patient interview between 3 to 18 m... · Patients undergoing thoracotomy
Thoracic epidural anaesthesia probably leads to lower persistent pain 3 to 18 months after thoracotomy (We defined… compared with conventional pain control (moderate certainty).
1 finding from 1 review
Intervention not reported
Adverse effects of continuous local anaesthetic infusion ‐ not reported · women with breast cancer undergoing elective surgery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse effects of epidural anaesthesia ‐ not reported · Patients undergoing thoracotomy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found